The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

Illinois secured a $45 million settlement with CVS Caremark over pharmacy benefit management transparency issues.

SPRINGFIELD - The Illinois Office of the Attorney General (OAG) reached a settlement on behalf of the Illinois Department of ...

Illinois officials indicated that the settlement is about a larger issue than just a contract dispute with one PBM.

The common theme at the maker of Wegovy and at UnitedHealth may be investors' sudden awareness of cost-cutting pressure.

Allison Stange lost 40 pounds since starting Zepbound in April 2024, improving both her blood pressure and sleep apnea. Now ...

President Donald Trump's new health care initiative aims to reduce prescription drug costs by targeting pharmacy benefit managers, commonly known as PBMs.

Iowa, suggested Congress could once again move to overhaul PBMs’ controversial business practices after legislators pass ...

In addition to eliciting greater weight loss than Novo Nordisk’s Wegovy, Eli Lilly’s Zepbound does not come at the expense of ...

The Most Favored Nation directive would allow drugmakers to directly sell their products to patients at a lower cost, cutting ...

CVS Health Corporation CVS and The Cigna Group CI shares trading lower Tuesday. President Donald Trump on Monday signed an ...